Blueprint Medicines
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Founded in 2011
blueprintmedicines.comInaccurate data? Flag it here.Open jobs at Blueprint Medicines
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.